Tempur Sealy International Inc Stock Upgraded (TPX)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

NEW YORK ( TheStreet) -- Tempur Sealy International (NYSE: TPX) has been upgraded by TheStreet Ratings from hold to buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income, solid stock price performance, impressive record of earnings per share growth and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:
  • TPX's very impressive revenue growth greatly exceeded the industry average of 17.3%. Since the same quarter one year prior, revenues leaped by 79.9%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Household Durables industry. The net income increased by 119.2% when compared to the same quarter one year prior, rising from $12.50 million to $27.40 million.
  • Powered by its strong earnings growth of 120.00% and other important driving factors, this stock has surged by 33.94% over the past year, outperforming the rise in the S&P 500 Index during the same period. We feel that the stock's sharp appreciation over the last year has driven it to a price level which is now somewhat expensive compared to the rest of its industry. The other strengths this company shows, however, justify the higher price levels.
  • TEMPUR SEALY INTL INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, TEMPUR SEALY INTL INC reported lower earnings of $1.27 versus $1.67 in the prior year. This year, the market expects an improvement in earnings ($2.77 versus $1.27).
  • 41.23% is the gross profit margin for TEMPUR SEALY INTL INC which we consider to be strong. Despite the high profit margin, it has decreased significantly from the same period last year. Despite the mixed results of the gross profit margin, TPX's net profit margin of 3.90% compares favorably to the industry average.

Tempur Sealy International, Inc. develops, manufactures, markets, and distributes bedding products in North America and internationally. The company provides mattresses, foundations, adjustable bases, and other products, including pillows and other accessories. Tempur Sealy International has a market cap of $3.59 billion and is part of the consumer goods sector and consumer durables industry. Shares are up 8% year to date as of the close of trading on Wednesday.

You can view the full Tempur Sealy International Ratings Report or get investment ideas from our investment research center.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

If you liked this article you might like

Stocks Mostly Lower in Cautious Trading, Apple Slips on Downgrade

Stocks Mostly Lower in Cautious Trading, Apple Slips on Downgrade

Stocks Under Pressure After London Terror Attacks, Apple Downgrade

Stocks Under Pressure After London Terror Attacks, Apple Downgrade

Stocks to Retreat From Records at the Open After London Terror Attacks

Stocks to Retreat From Records at the Open After London Terror Attacks

Insiders Are Loading Up on Kite Pharma, Cliffs Natural Resources and More

Insiders Are Loading Up on Kite Pharma, Cliffs Natural Resources and More